relapsed chronic lymphocytic leukemia (cll) global clinical trials review, h1, 2014

5
Relapsed Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014 Reportstack Reportstack Contact - [email protected]

Upload: reportstack

Post on 06-Mar-2016

214 views

Category:

Documents


1 download

DESCRIPTION

“Relapsed Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014" provides data on the Relapsed Chronic Lymphocytic Leukemia (CLL) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Relapsed Chronic Lymphocytic Leukemia (CLL). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Relapsed Chronic Lymphocytic Leukemia (CLL). Please email us at [email protected] or visit the http://www.reportstack.com/product/156795/relapsed-chronic-lymphocytic-leukemia-cll-global-clinical-trials-review-h1-2014.html to know more details

TRANSCRIPT

Page 1: Relapsed chronic lymphocytic leukemia (cll) global clinical trials review, h1, 2014

Relapsed Chronic Lymphocytic Leukemia (CLL) Global Clinical

Trials Review, H1, 2014

Reportstack

Reportstack Contact - [email protected]

Page 2: Relapsed chronic lymphocytic leukemia (cll) global clinical trials review, h1, 2014

Reportstack Contact - [email protected]

Summary

“Relapsed Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014" provides data on the Relapsed Chronic Lymphocytic Leukemia (CLL) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Relapsed Chronic Lymphocytic Leukemia (CLL). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Relapsed Chronic Lymphocytic Leukemia (CLL). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.

Page 3: Relapsed chronic lymphocytic leukemia (cll) global clinical trials review, h1, 2014

Reportstack Contact - [email protected]

Scope of the report

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Page 4: Relapsed chronic lymphocytic leukemia (cll) global clinical trials review, h1, 2014

Key Benefits

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Reportstack Contact - [email protected]

Page 5: Relapsed chronic lymphocytic leukemia (cll) global clinical trials review, h1, 2014

Reportstack Contact - [email protected]

If you are interested...

Contact Sudha B Email: [email protected] Ph:+1-888-789-6604 http://www.reportstack.com